ID

15746

Beschreibung

Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01697631

Link

https://clinicaltrials.gov/show/NCT01697631

Stichworte

  1. 10.06.16 10.06.16 -
Hochgeladen am

10. Juni 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes NCT01697631

Eligibility Diabetes NCT01697631

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01697631
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes
Beschreibung

type 2 diabetes

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
current treatment with conventional biphasic human insulin 30/70 b.i.d. (twice daily) for at least 3 months
Beschreibung

conventional biphasic human insulin

Datentyp

boolean

Alias
UMLS CUI [1]
C0356369
hba1c (glycosylated haemoglobin) equal to or below 12%
Beschreibung

hba1c

Datentyp

boolean

Alias
UMLS CUI [1]
C0019018
willing and able to perform self blood glucose monitoring (smbg)
Beschreibung

self blood glucose monitoring

Datentyp

boolean

Alias
UMLS CUI [1]
C0005803
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of drug or alcohol dependence
Beschreibung

drug or alcohol dependence

Datentyp

boolean

Alias
UMLS CUI [1]
C0038586
mental incapacity, unwillingness or language barriers precluding adequate understanding or co-operation
Beschreibung

language barriers

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0162340
previous participation in this trial
Beschreibung

previous participation in this trial

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
receipt of any investigational drug within the last month prior to this trial
Beschreibung

investigational drug

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
known or suspected allergy to trial products or related products
Beschreibung

allergy to trial products

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3854006

Ähnliche Modelle

Eligibility Diabetes NCT01697631

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01697631
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
type 2 diabetes
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
conventional biphasic human insulin
Item
current treatment with conventional biphasic human insulin 30/70 b.i.d. (twice daily) for at least 3 months
boolean
C0356369 (UMLS CUI [1])
hba1c
Item
hba1c (glycosylated haemoglobin) equal to or below 12%
boolean
C0019018 (UMLS CUI [1])
self blood glucose monitoring
Item
willing and able to perform self blood glucose monitoring (smbg)
boolean
C0005803 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
drug or alcohol dependence
Item
history of drug or alcohol dependence
boolean
C0038586 (UMLS CUI [1])
language barriers
Item
mental incapacity, unwillingness or language barriers precluding adequate understanding or co-operation
boolean
C0021430 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0162340 (UMLS CUI [1,3])
previous participation in this trial
Item
previous participation in this trial
boolean
C2348568 (UMLS CUI [1])
investigational drug
Item
receipt of any investigational drug within the last month prior to this trial
boolean
C2348568 (UMLS CUI [1])
allergy to trial products
Item
known or suspected allergy to trial products or related products
boolean
C0020517 (UMLS CUI [1,1])
C3854006 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video